Design, Synthesis, and Structure−Activity Relationships of Novel 2-Substituted Pyrazinoylguanidine Epithelial Sodium Channel Blockers: Drugs for Cystic Fibrosis and Chronic Bronchitis
暂无分享,去创建一个
R. Boucher | A. Usyatinsky | B. Sargent | A. Hirsh | B. F. Molino | M. R. Johnson | W. Geiss | M. Wyle | Andra Zamurs | Jianzhong Zhang | Brian Swenson | N. Astakhova | Rick T. Smith